2022; 20(3): 403~583
Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
Calogero Crapanzano, Ilaria Casolaro, Chiara Amendola, Stefano Damiani
2022; 20(3): 403-414  
Original Articles
Alterations of Power Spectral Density in Salience Network during Thought-action Fusion Induction Paradigm in Obsessive-compulsive Disorder
Sang Won Lee, Eunji Kim, Tae Yang Jang, Heajung Choi, Seungho Kim, Huijin Song, Moon Jung Hwang, Yongmin Chang, Seung Jae Lee
2022; 20(3): 415-426  
Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting
Young-Chul Chung, Yen Kuang Yang, Ahmad Hatim Sulaiman, Paul Bergmans, Wilson Tan
2022; 20(3): 427-439  
Apnea-hypopnea Index is Correlated with Pulse Rate in Patients with Sleep-related Breathing Disorder without Hypertension, Cardiovascular Disease, or Diabetes Mellitus
Jeonggeun Moon, Jae Hyoung Park, Seo-Eun Cho, Kwang-Pil Ko, Seung-Heon Shin, Ji-Eun Kim, Jae Kean Ryu, Seung-Gul Kang
2022; 20(3): 440-449  
Machine-Learning for Prescription Patterns: Random Forest in the Prediction of Dose and Number of Antipsychotics Prescribed to People with Schizophrenia
Mattia Marchi, Giacomo Galli, Gianluca Fiore, Andrew Mackinnon, Giorgio Mattei, Fabrizio Starace, Gian M. Galeazzi
2022; 20(3): 450-461  
Methylome-wide Association Study of Patients with Recent-onset Psychosis
Yan-Hong Piao, Yin Cui, Fatima Zahra Rami, Ling Li, Maryam Karamikheirabad, Shi Hyun Kang, Sung-Wan Kim, Jung Jin Kim, Bong Ju Lee, Young-Chul Chung
2022; 20(3): 462-473  
Brain Region and Sex-specific Changes in Mitochondrial Biogenesis Induced by Acute Trimethyltin Exposure
Jung Ho Lee, Eun Hye Jang, Soon Ae Kim
2022; 20(3): 474-481  
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time
Marc Ferrer, Óscar Soto-Angona, María Soler-Artigas, Pol Ibáñez, Christian Fadeuilhe, Raúl Felipe Palma-Álvarez, Raquefet Lidai, Sebastian Vargas-Cáceres, María Ángeles Torrecilla, Anna López, Josep Antoni Ramos-Quiroga
2022; 20(3): 482-490  
Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study
Sung Joon Cho, Jungmee Kim, Jin Yong Lee, Jee Hoon Sohn
2022; 20(3): 491-497  
Psychiatric Comorbidities in Adults with DiGeorge Syndrome
Hiren Patel, Ramu Vadukapuram, Zeeshan Mansuri, Chintan Trivedi, Kanwarjeet Singh Brar, Uzma Beg, Jigar Patel, Aalamgeer Ibrahim, Muhammad Khalid Zafar
2022; 20(3): 498-503  
Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms
Ece Yazla, Huseyin Kayadibi, Ihsan Cetin, Unsal Aydinoglu, Mehmet Emrah Karadere
2022; 20(3): 504-513  
The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder
Eun Jin Park, Young-Min Park, Seung-Hwan Lee, Bongseog Kim
2022; 20(3): 514-525  
Haloperidol and Other Antipsychotics Exposure before Endometrial Cancer Diagnosis: A Population-based Case-control Study
Wei-Ling Chen, Srinivasan Nithiyanantham, Yan-Chiao Mao, Chih-Hsin Muo, Chih-Pin Chuu, Shih-Ping Liu, Min-Wei Huang, Kuan-Pin Su
2022; 20(3): 526-535  
Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis
Saaya Yokoyama, Norio Sugawara, Kazushi Maruo, Norio Yasui-Furukori, Kazutaka Shimoda
2022; 20(3): 536-547  
Safety and Effectiveness of Desvenlafaxine in Korean Patients with Major Depressive Disorder: A 6-month Postmarketing Surveillance Study
Sungwon Roh, Kang Soo Lee, Songhwa Choi, Jae-Min Kim
2022; 20(3): 548-559  
Clinical Application Value of Lactobacillus Plantarum PS128 in Patients with Anxiety Disorders
Xiaojuan Meng, Yajie Gao, Hang Qi, Yongyan Ding, Yaqing Sun
2022; 20(3): 560-566  
Brief Reports
Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
Young Sup Woo, Sung-Yong Park, Bo-Hyun Yoon, Won-Seok Choi, Sheng-Min Wang, Won-Myong Bahk
2022; 20(3): 567-572  
The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea
Gyurin Kim, Soo Jung Rim, Minkyung Jo, Min Geu Lee, Se Jin Park, Subin Park
2022; 20(3): 573-577  
Case Reports
Pulmonary Embolism during a Retrial of Low-dose Clozapine
Gregg Alan Robbins-Welty, Shannon Coats, Andrew N. Tuck, Bryan K. Lao, Zachary Lane
2022; 20(3): 578-580  
Aripiprazole Improved Post-Streptococcal Dyskinesia by Modulating Dopaminergic Activity: A Case Report
Jae Hyun Ryou, Doug Hyun Han, Reeree Lee, Sun Mi Kim
2022; 20(3): 581-583  


A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects
Himanshu, Dharmila, Deepa Sarkar, Nutan
Received: January 14, 2020; Revised: March 25, 2020; Accepted: March 30, 2020
Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents
Jane Pei-Chen Chang, Kuan-Pin Su
Received: June 18, 2020; Accepted: June 24, 2020
Effects of Non-invasive Neurostimulation on Autism Spectrum Disorder: A Systematic Review
Ali Khaleghi, Hadi Zarafshan, Safa Rafiei Vand, Mohammad Reza Mohammadi
Received: February 24, 2020; Revised: June 8, 2020; Accepted: June 10, 2020
  • Official Journal

  • Associate Journal

Indexed/Covered by